S&P 500   3,899.95 (+2.33%)
DOW   31,591.58 (+2.13%)
QQQ   321.80 (+2.44%)
AAPL   125.83 (+3.77%)
MSFT   236.67 (+1.85%)
FB   260.69 (+1.19%)
GOOGL   2,053.95 (+1.58%)
TSLA   712.64 (+5.50%)
AMZN   3,118.10 (+0.81%)
NVDA   550.13 (+0.28%)
BABA   239.89 (+0.90%)
CGC   34.90 (+6.56%)
GE   13.27 (+5.82%)
MU   95.10 (+3.90%)
NIO   50.27 (+9.81%)
AMD   85.78 (+1.50%)
T   28.22 (+1.18%)
F   12.07 (+3.16%)
ACB   11.34 (+7.79%)
DIS   194.81 (+3.05%)
BA   224.76 (+6.01%)
NFLX   549.80 (+2.03%)
BAC   35.67 (+2.77%)
S&P 500   3,899.95 (+2.33%)
DOW   31,591.58 (+2.13%)
QQQ   321.80 (+2.44%)
AAPL   125.83 (+3.77%)
MSFT   236.67 (+1.85%)
FB   260.69 (+1.19%)
GOOGL   2,053.95 (+1.58%)
TSLA   712.64 (+5.50%)
AMZN   3,118.10 (+0.81%)
NVDA   550.13 (+0.28%)
BABA   239.89 (+0.90%)
CGC   34.90 (+6.56%)
GE   13.27 (+5.82%)
MU   95.10 (+3.90%)
NIO   50.27 (+9.81%)
AMD   85.78 (+1.50%)
T   28.22 (+1.18%)
F   12.07 (+3.16%)
ACB   11.34 (+7.79%)
DIS   194.81 (+3.05%)
BA   224.76 (+6.01%)
NFLX   549.80 (+2.03%)
BAC   35.67 (+2.77%)
S&P 500   3,899.95 (+2.33%)
DOW   31,591.58 (+2.13%)
QQQ   321.80 (+2.44%)
AAPL   125.83 (+3.77%)
MSFT   236.67 (+1.85%)
FB   260.69 (+1.19%)
GOOGL   2,053.95 (+1.58%)
TSLA   712.64 (+5.50%)
AMZN   3,118.10 (+0.81%)
NVDA   550.13 (+0.28%)
BABA   239.89 (+0.90%)
CGC   34.90 (+6.56%)
GE   13.27 (+5.82%)
MU   95.10 (+3.90%)
NIO   50.27 (+9.81%)
AMD   85.78 (+1.50%)
T   28.22 (+1.18%)
F   12.07 (+3.16%)
ACB   11.34 (+7.79%)
DIS   194.81 (+3.05%)
BA   224.76 (+6.01%)
NFLX   549.80 (+2.03%)
BAC   35.67 (+2.77%)
S&P 500   3,899.95 (+2.33%)
DOW   31,591.58 (+2.13%)
QQQ   321.80 (+2.44%)
AAPL   125.83 (+3.77%)
MSFT   236.67 (+1.85%)
FB   260.69 (+1.19%)
GOOGL   2,053.95 (+1.58%)
TSLA   712.64 (+5.50%)
AMZN   3,118.10 (+0.81%)
NVDA   550.13 (+0.28%)
BABA   239.89 (+0.90%)
CGC   34.90 (+6.56%)
GE   13.27 (+5.82%)
MU   95.10 (+3.90%)
NIO   50.27 (+9.81%)
AMD   85.78 (+1.50%)
T   28.22 (+1.18%)
F   12.07 (+3.16%)
ACB   11.34 (+7.79%)
DIS   194.81 (+3.05%)
BA   224.76 (+6.01%)
NFLX   549.80 (+2.03%)
BAC   35.67 (+2.77%)
Log in
TSE:APHA

Aphria Stock Forecast, Price & News

C$24.14
+1.41 (+6.20 %)
(As of 03/1/2021 11:45 AM ET)
Add
Compare
Today's Range
C$23.19
Now: C$24.14
C$24.49
50-Day Range
C$10.86
MA: C$19.13
C$33.37
52-Week Range
C$2.65
Now: C$24.14
C$40.93
Volume2.54 million shs
Average Volume8.21 million shs
Market CapitalizationC$7.65 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Aphria logo

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone844-427-4742
Employees1,200
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$601.85 million
Cash FlowC$0.63 per share
Book ValueC$5.98 per share

Profitability

Miscellaneous

Market CapC$7.65 billion
Next Earnings Date4/12/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

0.77 out of 5 stars

Analyst Opinion: 1.3Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
C$24.14
+1.41 (+6.20 %)
(As of 03/1/2021 11:45 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APHA News and Ratings via Email

Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aphria (TSE:APHA) Frequently Asked Questions

Is Aphria a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Aphria stock.
View analyst ratings for Aphria
or view top-rated stocks.

What stocks does MarketBeat like better than Aphria?

Wall Street analysts have given Aphria a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Aphria wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Aphria's next earnings date?

Aphria is scheduled to release its next quarterly earnings announcement on Monday, April 12th 2021.
View our earnings forecast for Aphria
.

How has Aphria's stock price been impacted by Coronavirus?

Aphria's stock was trading at C$3.68 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, APHA stock has increased by 538.6% and is now trading at C$23.50.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for APHA?

6 analysts have issued 12-month target prices for Aphria's shares. Their forecasts range from C$8.00 to C$20.00. On average, they anticipate Aphria's stock price to reach C$14.17 in the next year. This suggests that the stock has a possible downside of 39.7%.
View analysts' price targets for Aphria
or view top-rated stocks among Wall Street analysts.

Who are Aphria's key executives?

Aphria's management team includes the following people:
  • Mr. Irwin D. Simon, CEO & Chairman (Age 63, Pay $6.54M)
  • Mr. Carl A. Merton, Chief Financial Officer
  • Dr. Christelle Gedeon L.L.B., Ph.D., Chief Legal Officer
  • Mr. James R. Meiers, Chief Operating Officer of Aphria Leamington
  • Ms. Denise Menikheim Faltischek, Chief Strategy Officer & MD of Aphria Germany (Age 48, Pay $562.35k)
  • Mr. John B. Sadler, VP of Investor Relations
  • Mr. Bernard Yeung, Sr. VP of Sales & Marketing
  • Mr. Victor Neufeld, Special Advisor (Age 67)
  • Mr. Cole Cacciavillani, Special Advisor (Age 66)
  • Mr. Randy Daigneau, Sr. VP of Supply Chain

Who are some of Aphria's key competitors?

What other stocks do shareholders of Aphria own?

What is Aphria's stock symbol?

Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APHA."

How do I buy shares of Aphria?

Shares of APHA and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Aphria's stock price today?

One share of APHA stock can currently be purchased for approximately C$23.50.

How much money does Aphria make?

Aphria has a market capitalization of C$7.44 billion and generates C$601.85 million in revenue each year.

How many employees does Aphria have?

Aphria employs 1,200 workers across the globe.

What is Aphria's official website?

The official website for Aphria is www.aphria.com.

Where are Aphria's headquarters?

Aphria is headquartered at 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada.

How can I contact Aphria?

Aphria's mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada. The company can be reached via phone at 844-427-4742.


This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.